Amanda Vitória Rodrigues Dos Santos

Mrs. Amanda Vitória Rodrigues Dos Santos

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
Pedro Omar Batista PereiraPedro Omar Batista Pereira
Pedro Omar Batista Pereira
MSMateus Pinheiro de Souza
Mateus Pinheiro de Souza
LMLaura Beatriz Argôlo Moreira
Laura Beatriz Argôlo Moreira
EFEumar Soares Silva Filho Filho
Eumar Soares Silva Filho Filho
ESEdjan da Silva Santos
Edjan da Silva Santos
Francisco LeitãoFrancisco Leitão
Francisco Leitão
Background/Objectives: Maternal mortality due to abortion in Brazil has shown a significant decline of 47.37% between 1996 and 2022. This study aims to analyze temporal trends in maternal mortality due to abortion across regions and sociodemographic groups, highlighting disparities and their implications for public health. Methods: Trends were assessed using Prais–Winsten regression models to estimate the annual percentage change (APC). Data were stratified by region and sociodemographic characteristics to identify vulnerable groups. Results: The findings reveal notable regional disparities, with some regions experiencing more pronounced declines than others. Vulnerable sociodemographic groups, including women with lower levels of education and younger age groups, exhibited persistently higher mortality rates. Conclusions: Despite a significant overall reduction in maternal mortality due to abortion, disparities remain among regions and sociodemographic groups. These findings underscore the need for targeted public health policies aimed at reducing inequalities and addressing the needs of the most affected populations.

2 April 2026 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
MKMohamed Chouky Kamar
Mohamed Chouky Kamar
PCPablo Enrique Astudillo Coello
Pablo Enrique Astudillo Coello
ASAmanda Vitória Rodrigues Dos Santos
Amanda Vitória Rodrigues Dos Santos
SMSilviane Leite Melo
Silviane Leite Melo
Background: Laparoscopic sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are the most performed bariatric procedures worldwide. Trials and observational studies up to five years show RYGB yields slightly greater weight loss and better metabolic control, notably for dyslipidemia and reflux. Ten-year cohorts and recent randomized trials give perspective on durability differences, but small sample sizes and single-center designs limit their reach. No meta-analysis has yet pooled these decade-long data, leaving clinicians without clear guidance on the comparative long-term performance of SG and RYGB. Objective: This meta-analysis aims to compare the 10-year outcomes of SG versus RYGB in terms of weight loss and remission of comorbidities. Methods: We performed a systematic review and meta-analysis of randomized clinical trials (RCTs) and observational cohorts with a minimum 10-year follow-up. We searched PubMed, Embase, and Cochrane through April 2025. Primary endpoints were percent total weight loss (%TWL) and percent excess weight loss (%EWL). Secondary endpoints were remission of type 2 diabetes (T2D), hypertension, and dyslipidemia. Data were pooled using a random-effects model with risk ratio (RR) and mean difference (MD). Statistical analysis were made using R v.4.3.5. Results: RYGB produced greater long-term weight loss than SG (%TWL mean difference −2.38, 95% CI − 3.85 to − 0.92, p = 0.001; %EWL mean difference − 4.92, 95% CI − 8.67 to − 1.17, p = 0.01). Remission of T2D (RR 0.88, 95% CI 0.67 to 1.15, p = 0.36) and dyslipidemia (RR 0.84, 95% CI 0.64 to 1.09, p = 0.18) did not differ. Hypertension remission trended toward RYGB without reaching significance (RR 0.68, 95% CI 0.39 to 1.20, p = 0.19). SG showed higher rates of de-novo or worsening gastro-esophageal reflux disease and a markedly higher conversion to RYGB. Conclusion: The decadal outcomes of SG and RYGB reveal a level of parity that challenges historical procedural endorsements. Fidelity to the data indicates that ten years after surgery, there is no statistically or clinically significant difference in total weight loss or excess weight loss between the two techniques. Furthermore, the remission of major metabolic comorbidities, including type 2 diabetes and dyslipidemia, is comparable across both cohorts.

27 June 2025 in Journal of Face Aesthetics
Verified
Journal Article
Open access
PDF file
ASAmanda Vitória Rodrigues Dos Santos
Amanda Vitória Rodrigues Dos Santos
Ana Clara Ferreira AsbequeAna Clara Ferreira Asbeque
Ana Clara Ferreira Asbeque
MMMauro José De Deus Morais
Mauro José De Deus Morais
Francisco LeitãoFrancisco Leitão
Francisco Leitão
Introduction. Hypertrophic scars and keloids are consequences of abnormalities in the healing process and tissue repair, characterized by excessive fibrosis present throughout the wound distribution. In this sense, there are several extrinsic and intrinsic factors that corroborate the hypertrophic healing process. Aim. To analyze which morphological and metabolic factors accentuate the incidence of hypertrophic scars and keloids in healing processes in the last five years. Material and methods. Systematic review study without meta-analysis outlined by the PRISMA protocol and registered in PROSPERO from the literature bases in the broad area of ​​knowledge of Health Science: PubMed, Virtual Health Library (BVS), Periódico Capes and LILACS. The research was carried out by crossing the following descriptors: “plastic surgery”, “hypertrophic scar” and “healing”, in which articles written and published from 2020 to 2023 were used. Results. Molecular aspects of tissue modulation, hypertension, genetic factors of single nucleotide polymorphisms and factors related to lifestyle can influence the occurrence of abnormal scars. Conclusions. Hypertrophic scars and keloids are related to extrinsic and intrinsic factors, such as metabolic causes and the patient's postoperative course.

17 December 2025 in Clinics Biopsychosocial
Verified
Journal Article
Open access
GTGiovana Cristo de Oliveira Terças
Giovana Cristo de Oliveira Terças
FGFranciely Gomes Gonçalves
Franciely Gomes Gonçalves
IAInês Nalita D’aVila de Lima Alencar
Inês Nalita D’aVila de Lima Alencar
RLRita de Cássia Felipe de Lima
Rita de Cássia Felipe de Lima
FQFabiano Del Águila Queiroz
Fabiano Del Águila Queiroz
Francisco LeitãoFrancisco Leitão
Francisco Leitão
Introdução: O melanoma e outras neoplasias malignas da pele representam um desafio crescente para a saúde pública devido à sua alta letalidade e ao aumento da incidência global. No Brasil, o câncer de pele é o mais frequente, e embora o melanoma represente uma pequena parcela dos casos, ele é responsável por uma alta taxa de mortalidade. Objetivo: Analisar a mortalidade por melanoma e outras neoplasias malignas da pele no Brasil entre 2015 e 2024 considerando as diferenças regionais e os principais fatores epidemiológicos, como sexo, idade e raça/cor. Método: Trata-se de um estudo retrospectivo, observacional e ecológico, baseado em dados do Sistema de Informação sobre Mortalidade (SIM), do DATASUS. Foram incluídos óbitos registrados entre 2015 e 2024, classificados sob os códigos CID-10 C43-C44. As variáveis analisadas incluíram região geográfica, sexo, faixa etária e raça/cor. Os dados foram tabulados e analisados utilizando estatísticas descritivas no Microsoft Excel 2019. Resultado: No período analisado, foram registrados 43.956 óbitos por melanoma e outras neoplasias malignas da pele no Brasil. O ano de 2023 apresentou o maior número de óbitos. A mortalidade foi maior no Sudeste, seguido pelo Nordeste e Sul, sendo que a região Sul apresentou a maior taxa de mortalidade proporcional à população. O perfil epidemiológico predominante foi de indivíduos do sexo masculino (57,54%), idosos acima de 80 anos (38,72%) e de raça/cor branca (73,60%). Conclusão: A mortalidade apresentou um aumento significativo no Brasil na última década, com diferenças regionais relevantes.

17 December 2025 in Clinics Biopsychosocial
Verified
Journal Article
Open access
RLRita de Cássia Felipe de Lima
Rita de Cássia Felipe de Lima
FGFranciely Gomes Gonçalves
Franciely Gomes Gonçalves
IAInês Nalita D’aVila de Lima Alencar
Inês Nalita D’aVila de Lima Alencar
FQFabiano Del Águila Queiroz
Fabiano Del Águila Queiroz
GTGiovana Cristo de Oliveira Terças
Giovana Cristo de Oliveira Terças
Francisco LeitãoFrancisco Leitão
Francisco Leitão
Introduction: Skin cancer is one of the most prevalent neoplasms in Brazil, especially in rural areas, where cumulative sun exposure tends to be intense. Ultraviolet radiation is the main risk factor, leading to mutations that can develop into melanoma (more lethal) or non-melanoma. Objective: This study addressed, through a systematic review, whether rural residents have a higher prevalence of skin cancer when compared to urban populations. Method: A systematic review without meta-analysis was performed according to the PRISMA 2023 guidelines, registered in PROSPERO, with searches in the PubMed, BVS, and LILACS databases. Studies published between 2020 and 2025 on the diagnosis of skin cancer in rural areas were included. After screening according to inclusion and exclusion criteria, seven studies were included in the final sample. Results: A higher prevalence of skin cancer was found in rural areas, related to advanced stages and late diagnoses. Socioeconomic and demographic factors, such as age, income, and skin type, interfered with predisposition. Rural residents face restricted access to specialized services and travel longer distances for treatment. Occupational sun exposure was a determining factor in incidence. Conclusion: Significant disparities between rural and urban areas are evident, resulting from structural inequalities, lack of information on photoprotection, and occupational risks. Public policies focused on prevention, early detection, and greater access to specialized services can reduce the incidence and mortality of skin cancer among rural populations.

23 July 2024 in Revista de Epidemiologia e Saúde Pública - RESP
Verified
Journal Article
Closed access
PDF file
Ana Clara Ferreira AsbequeAna Clara Ferreira Asbeque
Ana Clara Ferreira Asbeque
MMMAURO JOSÉ DE MORAIS
MAURO JOSÉ DE MORAIS
MAMarcos Cordeiro Araripe
Marcos Cordeiro Araripe
ASAmanda Vitória Rodrigues Dos Santos
Amanda Vitória Rodrigues Dos Santos
Pedro Omar Batista PereiraPedro Omar Batista Pereira
Pedro Omar Batista Pereira
Francisco LeitãoFrancisco Leitão
Francisco Leitão
Objetivo: avaliar a incidência da mortalidade por obesidade e doença osteomuscular no período de 2019 a 2024. Método: revisão sistemática sem metanálise conforme protocolo padrão ouro Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) a partir dos artigos publicados nas mais robustas bases de literatura em ciências da saúde, a saber: PUBMED, Biblioteca Virtual em Saúde e Scientific Electronic Library Online (SciELO) utilizando Descritores em Ciências da Saúde. Os artigos publicados foram elegíveis ao atenderem aos seguintes critérios: (1) artigos que envolvem obesidade; (2) artigos que envolvem distúrbio musculoesquelético; (3) artigos que estudaram a mortalidade, e; (4) artigos publicados nos últimos 5 anos. Em julho foi feita a submissão na Base de protocolos de Revisões Sistemáticas PROSPERO, sob número 573900, para evitar duplicidade involuntária e reduzir o risco de viés de relato seletivo de desfecho. Resultados: dos 430 artigos encontrados, 13 preencheram os critérios de inclusão. Fatores como inatividade física, más alimentações contribuem significamente para casos de obesidade, consequentemente, excesso de tecido adiposo no quadril e membros inferiores provoca alterações mecânicas que podem comprometer a coordenação motora durante a marcha, resultando em doenças osteomusculares. Conclusão: As doenças osteomusculares são comuns entre trabalhadores, afetando saúde e desempenho. A obesidade e más condições de trabalho influenciam para a incidência da mortalidade de doenças crônicas e osteomusculares.